Cardiogenic Shock Due to Aluminum Phosphide Poisoning Treated with Intra-aortic Balloon Pump: A Report of Two Cases.
Omid MehrpourSadegh AsadiMohammad Ali YaghoubiNahid AzdakiNastaran MahmoodabadiSeyedYoosef JavadmoosaviPublished in: Cardiovascular toxicology (2020)
The mortality rate from aluminum phosphide (AlP) poisoning is as high as 70-100%, with refractory hypotension and severe metabolic acidosis being the two most common presentations in this poisoning. As this poisoning has no specific antidote, treatments revolve around supportive care. Cardiogenic shock created by toxic myocarditis is considered the main cause of mortality in these patients. Meanwhile, the intra-aortic balloon pump (IABP) has been suggested for the treatment of cardiogenic shock. This article reports the successful treatment of cardiogenic shock caused by AlP poisoning in a 17-year-old man and a 21-year-old woman using the IABP procedure.
Keyphrases
- end stage renal disease
- newly diagnosed
- aortic valve
- cardiovascular events
- ejection fraction
- healthcare
- chronic kidney disease
- left ventricular
- palliative care
- risk factors
- pulmonary artery
- cardiovascular disease
- emergency department
- early onset
- peritoneal dialysis
- type diabetes
- minimally invasive
- pain management
- quality improvement
- coronary artery disease
- chronic pain
- aortic dissection
- oxide nanoparticles